Skip to main content English

Detail

Clemens P. Spielvogel
Clemens P. Spielvogel, Ph.D.Postdoctoral Research Scientist | Medical Data Scientist

Department of Biomedical Imaging and Image-guided Therapy (Division of Nuclear Medicine)
Position: Research Associate (Postdoc)

ORCID: 0000-0002-4409-8324
T +43 1 40400 72350
clemens.spielvogel@meduniwien.ac.at

Keywords

Amyloidosis; Artificial Intelligence; Automatic Data Processing; Cardiac Imaging Techniques; Computational Biology; Data Mining; Decision Making, Computer-Assisted; Electronic Health Records; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Medical Informatics; Nuclear Medicine; Pattern Recognition, Automated

Research group(s)

Research interests

Discovery, development, and clinical assessment of novel biomarkers and clinical decision support systems.

Focus areas include nuclear medicine, oncological, and cardiovascular diseases.

Techniques, methods & infrastructure

  • Quantitative imaging markers
  • Machine learning
  • Vision-based deep learning
  • Explainable artificial intelligence
  • Automated image segmentation
  • Imaging / non-imaging data integration

 

Selected publications

  1. Spielvogel, C.P., Haberl D. et al. (2024) ‘Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study’, The Lancet Digital Health, 6(4), pp. e251–e260. Available at: https://doi.org/10.1016/s2589-7500(23)00265-0.
  2. Haberl, D. et al. (2024) ‘Multicenter PET image harmonization using generative adversarial networks’, European Journal of Nuclear Medicine and Molecular Imaging. Available at: https://doi.org/10.1007/s00259-024-06708-8.
  3. Spielvogel, C.P. et al. (2022) ‘Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer’, European Journal of Nuclear Medicine and Molecular Imaging, 50(2), pp. 546–558. Available at: https://doi.org/10.1007/s00259-022-05973-9.
  4. Ning, J., Spielvogel, C.P. et al. (2024) ‘A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study’, Theranostics, 14(12), pp. 4570–4581. Available at: https://doi.org/10.7150/thno.96921.
  5. Papp, L. et al. (2020) ‘Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI’, European Journal of Nuclear Medicine and Molecular Imaging, 48(6), pp. 1795–1805. Available at: https://doi.org/10.1007/s00259-020-05140-y.